KMID : 0043319900130020136
|
|
Archives of Pharmacal Research 1990 Volume.13 No. 2 p.136 ~ p.141
|
|
Differential Vasorelaxant Effects of KR-30075, a New Cyclic AMP-phosphodiesterase Inhibitor, on Guinea-pig Pulmonary, Bovine Coronary and Renal Arteries
|
|
Jung YS
Kwon KI/Zee OP
|
|
Abstract
|
|
|
The vasorelaxant effects of KR-30075 in guinea-pig pulmonary, bovine coronary and renal arterial strips contracted by either K+-depolarization, phenylephrine, or prostaglandin F2alpha(PGF2alpha)were evaluated. KR-30075 was more potent than imazodan as a vasorelaxant against PGF2alpha-induced contractions in bovine coronary and renal arteries, whereas against K+-induced contractions KR-30075 was less potent than imazodan in guinea-pig pulmonary arteries and more potent in bovine coronary arteries. KR-30075 was more potent against contractions induced by phenylephrine or PGF2alpha than the contractions induced by K+. This profile of activity for KR-30075 was similar to that of imazodan and dissimilar from the calcium entry blocking agent nifedipine. There was no vascular selectivity of KR-30075 between bovine coronary and renal arterial strip preparations. In conclusion, this study shows that KR-30075 represents the vasorelaxant effects on guinea-pig pulmonary, bovine coronary and renal arteries without specific vascular selectivity. The vasorelaxant profile of KR-30075, with different sources of vascular smooth muscle, is unlike that of calcium entry blocking agent and more similar to the profile of the agent that inhibit cyclic nucleotide phosphodiesterase.
|
|
KEYWORD
|
|
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|